Published:
Category: Group updates

The Roster Interface Program & Participants List Environment (Ripple) is a single electronic system which permits:

Read More

Published:
Category: Group updates
2022 Holiday Hours for CCTG, TTDR & BARL
During the holiday season the CCTG central offices will operate with limited coverage and there are key delivery dates for specimen shipments to keep in mind. Normal hours of operation and coverage will resume on Tuesday January 3, 2022. Read More

Published:
Category: Group updates
CCTG is actively seeking CRA representatives from Canadian Member sites to sit on Disease Site Committee Executives as well as the CCTG CRA Executive Committee. Read More

Published:
Category: News

Canadian Cancer Statistics provides comprehensive surveillance statistics on cancer in Canada. The full publication is produced every second year and includes detailed statistics on incidence, mortality and survival by sex, age group, geographic region and time period for 20+ cancer types.

Read More

Published:
Category: Publications
Three new publications: CRC6 Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study, CLC2 Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens, MAC20 The Breast Cancer Weight Loss trial: A description and evidence for the lifestyle intervention. Read More



Published:
Category: Group updates
Sadly we are informing everyone that CCTG Patient Representative Hamer-Wilson passed away last weekend. She was a vocal champion for clinical trials and lung cancer research who has supported the CCTG Lung Disease site committee since 2018. Jill will be greatly missed by our community and by those supporting lung cancer advocacy in Canada.
 
Judy Needham the CCTG Patient Representative Committee Chair shared her thoughts, "This is a tremendous loss for us, her family and the entire lung cancer community.
Read More

Published:
Category: Publications
Two new IND general review publications: Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022 and Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response Read More

Published:
Category: Publications

Adjuvant Palbociclib for ER+ Breast Cancer (PALLAS Trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13): A Preplanned Analysis of the Stage IIA Cohort

Read More